[go: up one dir, main page]

CR9171A - Nuevos compuestos - Google Patents

Nuevos compuestos

Info

Publication number
CR9171A
CR9171A CR9171A CR9171A CR9171A CR 9171 A CR9171 A CR 9171A CR 9171 A CR9171 A CR 9171A CR 9171 A CR9171 A CR 9171A CR 9171 A CR9171 A CR 9171A
Authority
CR
Costa Rica
Prior art keywords
new compounds
alkyl
ocf3
het
alkoxyalkyl
Prior art date
Application number
CR9171A
Other languages
English (en)
Spanish (es)
Inventor
Vincent Fish Paul
Ryckmans Thomas
Stobie Alan
Wakenhut Florian
Alistair Whitlock Gavilan
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of CR9171A publication Critical patent/CR9171A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CR9171A 2004-11-23 2007-06-07 Nuevos compuestos CR9171A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0425766.3A GB0425766D0 (en) 2004-11-23 2004-11-23 Novel compounds

Publications (1)

Publication Number Publication Date
CR9171A true CR9171A (es) 2007-07-04

Family

ID=33548739

Family Applications (1)

Application Number Title Priority Date Filing Date
CR9171A CR9171A (es) 2004-11-23 2007-06-07 Nuevos compuestos

Country Status (26)

Country Link
EP (1) EP1817281A1 (fr)
JP (1) JP4233596B2 (fr)
KR (1) KR100886294B1 (fr)
CN (1) CN101065355A (fr)
AP (1) AP2007004003A0 (fr)
AR (1) AR052243A1 (fr)
AU (1) AU2005308534A1 (fr)
BR (1) BRPI0518486A2 (fr)
CA (1) CA2589258A1 (fr)
CR (1) CR9171A (fr)
EA (1) EA011217B1 (fr)
GB (1) GB0425766D0 (fr)
GT (1) GT200500337A (fr)
IL (1) IL183191A0 (fr)
MA (1) MA29038B1 (fr)
MX (1) MX2007006138A (fr)
NL (2) NL1030485C2 (fr)
NO (1) NO20072486L (fr)
PA (1) PA8653501A1 (fr)
PE (1) PE20061056A1 (fr)
SV (1) SV2006002311A (fr)
TN (1) TNSN07201A1 (fr)
TW (1) TWI300776B (fr)
UY (1) UY29224A1 (fr)
WO (1) WO2006056884A1 (fr)
ZA (1) ZA200703910B (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH628885A5 (en) * 1978-01-01 1982-03-31 Anphar Sa Piperidine derivative
KR100803796B1 (ko) * 2003-06-17 2008-02-14 화이자 인코포레이티드 세로토닌 및 노르아드레날린 재흡수 억제제로서의n-피롤리딘-3-일-아미드 유도체
GB0314054D0 (en) * 2003-06-17 2003-07-23 Pfizer Ltd Amide derivatives as selective serotonin re-uptake inhibitors

Also Published As

Publication number Publication date
KR20070086599A (ko) 2007-08-27
NL1032760C2 (nl) 2007-04-17
JP4233596B2 (ja) 2009-03-04
ZA200703910B (en) 2008-09-25
EA200700920A1 (ru) 2007-12-28
AP2007004003A0 (en) 2007-06-30
GB0425766D0 (en) 2004-12-22
IL183191A0 (en) 2007-08-19
AU2005308534A1 (en) 2006-06-01
CN101065355A (zh) 2007-10-31
WO2006056884A1 (fr) 2006-06-01
NL1030485A1 (nl) 2006-05-24
GT200500337A (es) 2006-06-13
UY29224A1 (es) 2006-06-30
BRPI0518486A2 (pt) 2008-11-18
CA2589258A1 (fr) 2006-06-01
EA011217B1 (ru) 2009-02-27
TNSN07201A1 (fr) 2008-11-21
NL1032760A1 (nl) 2006-12-13
JP2008520646A (ja) 2008-06-19
MA29038B1 (fr) 2007-11-01
TWI300776B (en) 2008-09-11
TW200626543A (en) 2006-08-01
EP1817281A1 (fr) 2007-08-15
PE20061056A1 (es) 2006-11-08
PA8653501A1 (es) 2006-06-02
AR052243A1 (es) 2007-03-07
NO20072486L (no) 2007-06-20
MX2007006138A (es) 2007-07-19
NL1030485C2 (nl) 2006-11-07
KR100886294B1 (ko) 2009-03-04
SV2006002311A (es) 2006-09-14

Similar Documents

Publication Publication Date Title
ATE506354T1 (de) Substituierte arylcyclopropylacetamide als glucokinaseaktivatoren
DOP2010000194A (es) Derivados de oxadiazol activos sobre fosfato de esfingosina-1
CO5611127A2 (es) Derivados de indolilmaleimida
AR085150A1 (es) Agentes moduladores de s1p
ECSP088479A (es) Derivados de oxadiazol
EA201070895A1 (ru) Карбамидные производные тетрагидрохиноксалина, их получение и их применение в терапии
CO5611147A2 (es) Derivados de nicotinamida utiles como inhibidores p38
WO2010003809A3 (fr) Mélanges liquides d'ester de bis- et de tris-phosphite à pont oxyalkylène
AR055150A1 (es) Compuestos de isoindol - imido y composiciones que los comprenden y sus metodos de uso
EA200870336A1 (ru) Полициклические производные циннамида
AR043837A1 (es) Pirazoles sustituidos
CO6341609A2 (es) 5-heterociclilalquil-3-hidroxi-2-fenilciclopent-2-enonas como herbicidas.
MX2009012885A (es) Nuevo derivado de 1,2,3,4-tetrahidroquinoxalina que tiene, como sustituyente, grupo fenilo que tiene estructura de ester de acido sulfonico o estructura de amida de acido sulfonico introducida en este, y tiene actividad de enlace al receptor de gluco
ECSP088431A (es) Derivados de pirazolo
MY146663A (en) Organic sulfur compound and its use for controlling harmful arthropod
AR061806A1 (es) Derivados de alquilpiridazina como inhibidores de 11b-hsd1 (t2d)
CO5640131A2 (es) Compuestos de n-formil-hidroxilamina como inhibidores de pdf
MY150269A (en) Novel phenylpyrrole derivative
ECSP056232A (es) Nuevos compuestos
CO6321269A2 (es) Derivados de benzoxazinona que actuan como agonistas de receptores adrenergicos beta 2 para el tratamiento de transtornos respiratorios
AR062679A1 (es) Derivados de eter diarilico y usos de los mismos
AR083861A1 (es) OXAZOLIDINONAS COMO MODULADORES DE mGluR5 Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN
CO6190608A2 (es) Sal de potasio cristalina de analogos de lipoxina a4
ATE550332T1 (de) 4-imidazolin-2-onverbindungen als p38-map- kinaseinhibitors
DE602007013730D1 (de) Trehaloseverbindung und arzneimittel mit der verbindung

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)